US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

ProShares Ultra Nasdaq Biotechnology

118.55

+1.951.67%

Post-market: 118.41-0.1383-0.12%19:30 EDT

Volume:7K

Turnover:797.37K

Market Cap:103.14M

PE:- -

High:118.55

Open:115.47

Low:115.47

Close:116.60

52wk High:126.40

52wk Low:55.34

Shares:870.00K

Float Shares:870.00K

Volume Ratio:0.69

T/O Rate:0.78%

Dividend:0.33

Dividend Rate:0.27%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

AstraZeneca, Amgen Phase 3 Trial Shows Tezspire Eases Swallowing Difficulties for EoE Patients

MT Newswires Live

Vertex Corp. Added to JPX-Nikkei Mid and Small Cap Index for FY2026

Vertex Corp. Refines Leadership Structure at Key Subsidiary Vertex Co.

AstraZeneca-Amgen Asthma Drug Succeeds in Late-Stage Oesophagus Disease Trial

Amgen - Tezspire Safety Profile Consistent with Approved Indications

THOMSON REUTERS

Tezspire® Demonstrates Positive Phase 3 Results in Eosinophilic Esophagitis Across Both Co-Primary and All Key Secondary Endpoints

THOMSON REUTERS

Moderna Inc. Stock Falls 5.8%, Underperforms Peers

Gilead Sciences Updates Financial Calendar with Investor Conference Presentations

Vertex to Present at Wells Fargo Healthcare Investor Conference Fireside Chat

Sino Biopharmaceutical Stock Climbs 2.1% in Hong Kong, Outperforms Competitors

Gilead Sciences Inc. Stock Outperforms Competitors on Strong Trading Day

Moderna Inc. Stock Rallies 14.4%, Outperforms Peers

Political and General News Events from August 25

Viavi Solutions (VIAV) Could Be 40% Undervalued On Vertex 6.0 Launch

Simply Wall St.

Moderna Inc. Stock Slides 4.3%, Underperforms Peers

Amgen Inc. Stock Underperforms Monday When Compared to Competitors Despite Daily Gains

Lakefront Biotherapeutics Wins FDA Orphan Drug Status for Gamgertamig in Pemphigus

Amgen Extends MariTide Study In Obesity And Diabetes, Keeping Investor Focus On Long-Term Potential

Political and General News Events from August 24

EU Commission Approves Gilead Trodelvy-Keytruda Combo for First-Line PD-L1+ Metastatic TNBC

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://au1.tigerplaytime.com/stock/BIB/news?page=3"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BIB","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BIB\",,,,,undefined,":{"symbol":"BIB","market":"US","secType":"STK","nameCN":"ProShares Ultra Nasdaq Biotechnology","latestPrice":118.5483,"timestamp":1788292800000,"preClose":116.5968,"halted":0,"volume":6774,"hourTrading":{"tag":"盘后","latestPrice":118.41,"preClose":118.5483,"latestTime":"19:30 EDT","volume":63,"amount":7463.0398,"timestamp":1788305406177,"change":-0.1383,"changeRate":-0.001167,"amplitude":0},"delay":0,"changeRate":0.016737166028570217,"floatShares":870000,"shares":870000,"eps":0,"marketStatus":"Not Yet Opened","change":1.9515,"latestTime":"09-01 16:00:00 EDT","open":115.47,"high":118.5483,"low":115.47,"amount":797373.43338,"amplitude":0.026401,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":2,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1788336000000},"marketStatusCode":0,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":116.5968,"sharesOutstanding":1040000,"nav":116.4962,"aum":101351694,"dividendRate":0.002749,"bidAskSpread":0.002656,"preHourTrading":{"tag":"盘前","latestPrice":117.83,"preClose":116.5968,"latestTime":"08:59 EDT","volume":13,"amount":1531.79,"timestamp":1788267571078,"change":1.2332,"changeRate":0.010577,"amplitude":0},"postHourTrading":{"tag":"盘后","latestPrice":118.41,"preClose":118.5483,"latestTime":"19:30 EDT","volume":63,"amount":7463.0398,"timestamp":1788305406177,"change":-0.1383,"changeRate":-0.001167,"amplitude":0},"volumeRatio":0.693333,"impliedVol":0.4703,"impliedVolPercentile":0.6733},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BIB\",,,,,undefined,":{"symbol":"BIB","floatShares":870000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.693333,"shares":870000,"dividePrice":0.3259,"high":118.5483,"amplitude":0.026401,"preClose":116.5968,"low":115.47,"week52Low":55.34,"pbRate":"--","week52High":126.399,"institutionHeld":0,"latestPrice":118.5483,"eps":0,"divideRate":0.002749,"volume":6774,"delay":0,"ttmEps":0,"open":115.47,"prevYearClose":79.7794,"prevWeekClose":116.3898,"prevMonthClose":116.5968,"prevQuarterClose":100.74,"fiveDayClose":125.1901,"twentyDayClose":100.17,"sixtyDayClose":80.2719},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/BIB\",params:#limit:5,,,undefined,":[{"date":"2026-03-25","symbol":"BIB","amount":0.00714,"announcedDate":"2026-03-24","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-03-25","defaultRemindTime":1774445400000,"name":"Ultra纳斯达克生物科","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-03-31","payableDate":"2026-03-25","currency":"USD","dateTimestamp":1774411200000,"payDate":"2026-03-31"},{"date":"2025-12-24","symbol":"BIB","amount":0.134637,"announcedDate":"2025-12-23","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-24","defaultRemindTime":1766586600000,"name":"Ultra纳斯达克生物科","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-31","payableDate":"2025-12-24","currency":"USD","dateTimestamp":1766552400000,"payDate":"2025-12-31"},{"date":"2025-09-24","symbol":"BIB","amount":0.180541,"announcedDate":"2025-09-23","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-24","defaultRemindTime":1758720600000,"name":"Ultra纳斯达克生物科","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-30","payableDate":"2025-09-24","currency":"USD","dateTimestamp":1758686400000,"payDate":"2025-09-30"},{"date":"2025-06-25","symbol":"BIB","amount":0.170576,"announcedDate":"2025-06-24","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-25","defaultRemindTime":1750858200000,"name":"Ultra纳斯达克生物科","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-07-01","payableDate":"2025-06-25","currency":"USD","dateTimestamp":1750824000000,"payDate":"2025-07-01"},{"date":"2025-03-26","symbol":"BIB","amount":0.130939,"announcedDate":"2025-03-25","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-03-26","defaultRemindTime":1742995800000,"name":"Ultra纳斯达克生物科","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-04-01","payableDate":"2025-03-26","currency":"USD","dateTimestamp":1742961600000,"payDate":"2025-04-01"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"BIB\",market:\"US\",,,undefined,":[{"executeDate":"2022-12-22","recordDate":"2022-12-23","paymentDate":"2022-12-30","value":0.019852,"currency":"USD"},{"executeDate":"2023-12-20","recordDate":"2023-12-21","paymentDate":"2023-12-28","value":0.038393,"currency":"USD"},{"executeDate":"2024-03-20","recordDate":"2024-03-21","paymentDate":"2024-03-27","value":0.040324,"currency":"USD"},{"executeDate":"2024-06-26","recordDate":"2024-06-26","paymentDate":"2024-07-03","value":0.26476,"currency":"USD"},{"executeDate":"2024-09-25","recordDate":"2024-09-25","paymentDate":"2024-10-02","value":0.15285,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"BIB\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BIB\",pageSize:20,pageCount:3,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2662771175","title":"AstraZeneca, Amgen Phase 3 Trial Shows Tezspire Eases Swallowing Difficulties for EoE Patients","url":"https://stock-news.laohu8.com/highlight/detail?id=2662771175","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662771175?lang=en_us&edition=fundamental","pubTime":"2026-08-27 16:24","pubTimestamp":1787819085,"startTime":"0","endTime":"0","summary":"AstraZeneca  and Amgen  said Thursday their drug Tezspire met the primary endpoints of a Phase 3 trial treating eosinophilic esophagitis, a chronic inflammatory esophagus disorder.The medication met both primary endpoints by reducing tissue inflammation and easing swallowing difficulties at week 24 compared to a placebo, the companies said.The disease and symptom improvements were maintained through week 52 for both tested doses, they said.The companies also said the safety profile of the treatment during the study remained consistent with its previously approved uses.Shares of Amgen were down by over 1% in Thursday premarket activity.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["TBXU","AZNH","IE00B4R5TH58.HKD","BK4534","LU2462157665.USD","LU2237443622.USD","LU2242652126.USD","LU0058720904.USD","LU0889565916.HKD","BBH","LU2242646821.SGD","BK4533","PJP","LU0708994859.HKD","BK4585","LU2089984988.USD","LU2237443465.HKD","LU1057294990.SGD","LU1061106388.HKD","LU2237443978.SGD","LU2112291526.USD","LU2237443895.HKD","LU0128525929.USD","LU1267930573.SGD","BK4566","IE00BJT1NW94.SGD","LU2456880835.USD","IE00BFTCPJ56.SGD","LU0432979614.USD","LU1829250122.USD","BK4599","LU0029864427.USD","LU0310800379.SGD","AMGN","BIB","BK4581","IBBQ","AZN","IBB","LU0109394709.USD","LU2237443382.USD","LU0868494617.USD","LU1571399168.USD","IE00B2B36J28.USD","PBE","BK4007","LU2237443549.SGD","LU1983299246.USD","IE00BJJMRZ35.SGD","LU0289739699.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662775710","title":"Vertex Corp. Added to JPX-Nikkei Mid and Small Cap Index for FY2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2662775710","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662775710?lang=en_us&edition=fundamental","pubTime":"2026-08-27 14:55","pubTimestamp":1787813720,"startTime":"0","endTime":"0","summary":"The latest update is out from Vertex Corp. ( ($JP:5290) ). Vertex Corporation has been selected as a constituent of the JPX-Nikkei Mid and Small Ca...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/vertex-corp-added-to-jpx-nikkei-mid-and-small-cap-index-for-fy2026?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/vertex-corp-added-to-jpx-nikkei-mid-and-small-cap-index-for-fy2026?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IBBQ","SG9999001176.USD","IE0002141913.USD","SG9999013999.USD","BK4533","IE00BJT1NW94.SGD","SGXZ57979304.SGD","LU2456880835.USD","LU0432979614.USD","IE00B19Z9Z06.USD","LU1585245621.USD","BK4532","IDNA","LU1430594728.SGD","LU1069344957.HKD","LU2089984988.USD","LU1559883803.SGD","PBE","VERX","BBH","LU0823416689.USD","LU0109394709.USD","LU0566484027.USD","LU1093756168.USD","IE00BJJMRZ35.SGD","IE00B19Z3581.USD","IE0002270589.USD","LU2417539215.USD","LU2462157665.USD","JPX","LU1815336091.USD","BK4567","LU2468319806.SGD","VRTX","IE00BFTCPJ56.SGD","GNMX","IE00B19Z9P08.USD","IE00B4R5TH58.HKD","BK4023","BIB","TBXU","LU0289739699.SGD","LU0234570918.USD","IBB","BK4585","IE00BZ9MQY76.HKD","LU1778281490.HKD","LU0079474960.USD","IE00B2B36J28.USD","LU0058720904.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662477574","title":"Vertex Corp. Refines Leadership Structure at Key Subsidiary Vertex Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2662477574","media":"TIPRANKS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662477574?lang=en_us&edition=fundamental","pubTime":"2026-08-27 14:55","pubTimestamp":1787813711,"startTime":"0","endTime":"0","summary":"The latest update is out from Vertex Corp. ( ($JP:5290) ). Vertex Corporation has updated its earlier disclosures on changes to directors and offic...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/vertex-corp-refines-leadership-structure-at-key-subsidiary-vertex-co?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/vertex-corp-refines-leadership-structure-at-key-subsidiary-vertex-co?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4023","LU1815336091.USD","LU0320765992.SGD","SG9999001176.USD","TBXU","VRTX","BK4532","LU0058720904.USD","LU2362541273.HKD","BBH","LU2462157665.USD","GNMX","LU0234570918.USD","BK4139","LU1035775433.USD","BIB","LU1559883803.SGD","IE00B19Z9P08.USD","BK4585","LU2362541513.USD","LU0566484027.USD","IE00BZ9MQY76.HKD","BK4567","LU1674673428.USD","LU0109394709.USD","IE00B19Z9Z06.USD","IE00B2B36J28.USD","LU0417517546.SGD","LU0256863811.USD","IBBQ","LU0889565916.HKD","IE00BJT1NW94.SGD","BK4533","LU1430594728.SGD","LU2417539215.USD","SGXZ57979304.SGD","IE0002270589.USD","IBB","LU0061475181.USD","LU0289739699.SGD","LU0757428866.USD","VERX","LU0823416689.USD","LU2456880835.USD","LU1093756325.SGD","IDNA","IE00B19Z3581.USD","LU0079474960.USD","LU2236285917.USD","PBE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662514775","title":"AstraZeneca-Amgen Asthma Drug Succeeds in Late-Stage Oesophagus Disease Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2662514775","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662514775?lang=en_us&edition=fundamental","pubTime":"2026-08-27 14:40","pubTimestamp":1787812818,"startTime":"0","endTime":"0","summary":"UPDATE 3-AstraZeneca-Amgen asthma drug succeeds in late-stage oesophagus disease trialAug 27 (Reuters)-AstraZenecaAZN.Lsaid on Thursday its asthma drug Tezspire met the main goals of a late-stage tria","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260827:nL6N44O0DF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BIB","BBH","AMGN","LU0792757196.USD","LU1974910355.USD","LU2293690082.USD","AZN.UK","LU0310799852.SGD","TBXU","REGN","LU2237443382.USD","LU1267930490.SGD","LU0972486137.USD","LU1153584641.USD","LU0661504455.SGD","LU1880407132.USD","LU0640478417.SGD","LU0047473722.EUR","LU0052756011.USD","LU0823434583.USD","LU0997586515.USD","LU1119994496.HKD","03165","LU1170363599.USD","LU1481600234.SGD","IBB","IE00BFTCPJ56.SGD","LU3187612489.SGD","LU0738911758.USD","LU2242652126.USD","PBE","SGXZ57979304.SGD","BK4588","LU0345777659.USD","LU1057294990.SGD","LU1051770623.HKD","LU0266013472.USD","LU1003077747.HKD","LU2237443622.USD","PJP","LU0575583348.USD","LU0432979614.USD","BK4599","LU1571399168.USD","LU1829250122.USD","LU0077335932.USD","LU0997586432.USD","LU0887340254.USD","LU0122379950.USD","IBBQ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662778025","title":"Amgen - Tezspire Safety Profile Consistent with Approved Indications","url":"https://stock-news.laohu8.com/highlight/detail?id=2662778025","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662778025?lang=en_us&edition=fundamental","pubTime":"2026-08-27 14:00","pubTimestamp":1787810401,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260827:nTUA3XV48Z:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IBBQ","LU1023059063.AUD","LU0868494617.USD","BBH","BK4599","LU2242646821.SGD","BK4585","BIB","IE00BJJMRZ35.SGD","LU2112291526.USD","LU0109394709.USD","LU2468319806.SGD","IE0002141913.USD","BK4588","AMGN","LU2242652126.USD","LU0889565916.HKD","LU1057294990.SGD","IE0009355771.USD","IE00B2B36J28.USD","IE00B4R5TH58.HKD","BK4533","LU1571399168.USD","PBE","BK4581","BK4534","LU0320765992.SGD","IE00BFTCPJ56.SGD","PJP","SG9999001440.SGD","IE00BJT1NW94.SGD","LU1983299246.USD","IBB","LU0122379950.USD","BK4566","LU2089984988.USD","LU0289739699.SGD","LU0058720904.USD","TBXU","LU1061106388.HKD","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662728778","title":"Tezspire® Demonstrates Positive Phase 3 Results in Eosinophilic Esophagitis Across Both Co-Primary and All Key Secondary Endpoints","url":"https://stock-news.laohu8.com/highlight/detail?id=2662728778","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662728778?lang=en_us&edition=fundamental","pubTime":"2026-08-27 14:00","pubTimestamp":1787810401,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260827:nTUA3XV48Z:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4581","LU2468319806.SGD","LU0058720904.USD","IE00BJT1NW94.SGD","IE00B2B36J28.USD","IBBQ","LU2242652126.USD","BK4585","IE00BJJMRZ35.SGD","PJP","TBXU","IE00B4R5TH58.HKD","LU1057294990.SGD","LU0122379950.USD","IE0009355771.USD","BK4533","IE00BFTCPJ56.SGD","LU2112291526.USD","LU0868494617.USD","LU0320765992.SGD","BK4588","IE0002141913.USD","BK4566","LU1571399168.USD","BK4599","LU1023059063.AUD","LU2242646821.SGD","PBE","LU1061106388.HKD","LU0289739699.SGD","BK4534","IBB","LU0889565916.HKD","SG9999001440.SGD","AMGN","BIB","LU1983299246.USD","BK4139","LU2089984988.USD","BBH","LU0109394709.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662440957","title":"Moderna Inc. Stock Falls 5.8%, Underperforms Peers","url":"https://stock-news.laohu8.com/highlight/detail?id=2662440957","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662440957?lang=en_us&edition=fundamental","pubTime":"2026-08-27 04:33","pubTimestamp":1787776380,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Moderna Inc. slid 5.8% to $149.66 on what proved to be an all-around dismal trading session for the stock market, with the NASDAQ Composite Index falling 0.1% to 26,130.20 and Dow Jones Industrial Average falling 0.2% to 53,463.88.Moderna Inc. closed 15.3% short of its 52-week high of $176.66, which the company reached on August 19th.The stock underperformed when compared to some of its peers, as Johnson & Johnson fell 1.1% to $270.00, Pfizer Inc. fell 0.9% to $28.30, and Gilead Sciences Inc. fell 0.46% to $148.09.Trading volume totaled 21.8 million, compared to the 50-day average of 16.1 million.Data source: Dow Jones Market Data, FactSet","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BIB","LU0965508806.USD","LU0320765992.SGD","TBXU","MRNA","LU1057294990.SGD","IE00B19Z3581.USD","IBB","MRNY","LU1674673428.USD","BK4532","LU1037948541.HKD","LU0234570918.USD","LU1934455863.HKD","LU1061106388.HKD","LGHT","BK4534","GILD","LU0122379950.USD","LU2357627491.SGD","BK4548","IDNA","LU0058720904.USD","BK4585","IBBQ","LU2324357040.USD","LU0965509283.SGD","BK4551","LU2087621335.USD","SG9999015978.USD","WDNA","LU1585245621.USD","BK4578","BK4533","BBH","BMED","MEDI","IE0002270589.USD","LU1839511570.USD","MRNX","LU0861579265.USD","IE00BZ1G4Q59.USD","LU1571399168.USD","SG9999015952.SGD","TMED","LU0965509101.SGD","GNOM","LU1674673691.USD","LU0109394709.USD","IE00B7SZLL34.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662417787","title":"Gilead Sciences Updates Financial Calendar with Investor Conference Presentations","url":"https://stock-news.laohu8.com/highlight/detail?id=2662417787","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662417787?lang=en_us&edition=fundamental","pubTime":"2026-08-27 04:05","pubTimestamp":1787774725,"startTime":"0","endTime":"0","summary":"Gilead Sciences updates financial calendar with investor conference presentationsGilead executives will present at the Wells Fargo Annual Healthcare Conference on September 9 at 11:00 a.m. ET.Presenta","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260826:nNDL8cjLQm:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1066051498.USD","LU0109394709.USD","LU1037948897.HKD","IBBQ","LU0861579265.USD","LU0889565916.HKD","LU1674673691.USD","LU1934455277.USD","LU1778281490.HKD","BK4568","LU0234570918.USD","LU1585245621.USD","LU2087621335.USD","LU0122379950.USD","IE00B19Z3581.USD","BK4585","BK4588","LU0823416689.USD","BIB","IE0002270589.USD","TBXU","MEDI","IE00B3T34201.USD","LU1430594728.SGD","IE00B7SZLL34.SGD","LU2112291526.USD","BK4583","BK4550","LU0965508806.USD","LU1674673428.USD","LU1057294990.SGD","LU0859254822.USD","LU2089984988.USD","LU0965509010.AUD","IE00BZ1G4Q59.USD","LU1023059063.AUD","SG9999015952.SGD","TMED","LU1571399168.USD","LU0965509283.SGD","BBH","IBB","LU1037948541.HKD","GILD","LU0882574055.USD","BMED","LU1066053197.SGD","IE00BKVL7J92.USD","LU0289739699.SGD","BK4532"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662741464","title":"Vertex to Present at Wells Fargo Healthcare Investor Conference Fireside Chat","url":"https://stock-news.laohu8.com/highlight/detail?id=2662741464","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662741464?lang=en_us&edition=fundamental","pubTime":"2026-08-27 04:00","pubTimestamp":1787774425,"startTime":"0","endTime":"0","summary":"Vertex to present at Wells Fargo healthcare investor conference fireside chatVertex will join four investor conference fireside chats in September 2026, led by senior management.Wells Fargo 21st Annua","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260826:nNDL7VGD1d:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PBE","BK4533","LU1430594728.SGD","GNMX","SGXZ57979304.SGD","LU2462157665.USD","LU2089984988.USD","BK4139","LU1069344957.HKD","IE0009355771.USD","IE00BFTCPJ56.SGD","LU1674673691.USD","LU1093756168.USD","IE00B4R5TH58.HKD","IE00B19Z9P08.USD","IE00B19Z3581.USD","LU0417517546.SGD","LU0432979614.USD","SG9999001176.USD","LU2362541513.USD","BBH","LU0256863811.USD","IE00B19Z3B42.SGD","IE00B894F039.SGD","LU0320765992.SGD","IBBQ","LU0109394709.USD","IBB","LU0289739699.SGD","LU0058720904.USD","LU2468319806.SGD","LU1674673428.USD","LU1778281490.HKD","BIB","BK4567","SG9999013999.USD","IE00B19Z9Z06.USD","LU0079474960.USD","VRTX","LU0234570918.USD","LU2362540622.SGD","LU1035775433.USD","TBXU","IDNA","LU2417539215.USD","IE0002141913.USD","IE00B2B36J28.USD","LU0889565916.HKD","LU2362541273.HKD","IE00BJT1NW94.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662796495","title":"Sino Biopharmaceutical Stock Climbs 2.1% in Hong Kong, Outperforms Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2662796495","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662796495?lang=en_us&edition=fundamental","pubTime":"2026-08-26 16:32","pubTimestamp":1787733120,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Sino Biopharmaceutical Ltd. rallied 2.1% to 5.74 Hong Kong dollars on what proved to be an all-around favorable trading session for the Hong Kong stock market, with the Hang Seng Index rising 0.6% to 25652.97.This was the stock's second consecutive day of gains.Sino Biopharmaceutical Ltd. closed 37% below its 52-week high of HK$9.12, which the company reached Sept. 10.The stock outperformed some of its competitors, as CSPC Pharmaceutical Group Ltd. rose 1.2% and Amgen Inc. remained unchanged.Trading volume totaled 180.5 million shares, compared to the 50-day average of 101.5 million shares.Data source: Dow Jones Market Data, FactSet","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2242646821.SGD","IE00BJJMRZ35.SGD","LU1061106388.HKD","BK4534","BK1191","BK4581","IBB","LU0289739699.SGD","BBH","LU0122379950.USD","HK0000165453.HKD","IE00BZ08YT58.USD","LU2089984988.USD","LU1571399168.USD","PJP","LU1023059063.AUD","LU0320765992.SGD","AMGN","01177","BK4599","BK1515","IE0009355771.USD","PBE","LU1983299246.USD","BIB","LU2112291526.USD","BK4588","IE00BJT1NW94.SGD","TBXU","LU0889565916.HKD","IE00BZ08YR35.GBP","LU2468319806.SGD","LU0058720904.USD","BK4139","BK4585","BK4566","IE00B2B36J28.USD","IE00BFTCPJ56.SGD","LU2242652126.USD","IBBQ","BK1589","LU1057294990.SGD","SG9999001440.SGD","BK4533","BK1521","LU0868494617.USD","IE0002141913.USD","IE00B4R5TH58.HKD","LU0109394709.USD","IE00BZ08YS42.EUR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662175230","title":"Gilead Sciences Inc. Stock Outperforms Competitors on Strong Trading Day","url":"https://stock-news.laohu8.com/highlight/detail?id=2662175230","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662175230?lang=en_us&edition=fundamental","pubTime":"2026-08-26 04:35","pubTimestamp":1787690100,"startTime":"0","endTime":"0","summary":"DJ Gilead Sciences Inc. Stock Outperforms Competitors On Strong Trading DayThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Gilead Sciences Inc.  rose 1.38% to $148.77 Tuesday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index  rising 0.32% to 7,677.28 and the Dow Jones Industrial Average  rising 0.30% to 53,577.40.This was the stock's third consecutive day of gains.Gilead Sciences Inc. closed 5.42% below its 52-week high of $157.29, which the company achieved on February 11th.The stock demonstrated a mixed performance when compared to some of its competitors Tuesday, as Johnson & Johnson  rose 0.53% to $273.14, Pfizer Inc.  rose 2.15% to $28.57, and Abbott Laboratories  fell 0.46% to $116.13.Trading volume  remained 2.7 million below its 50-day average volume of 7.3 M.Data source: Dow Jones Market Data, FactSet. Data compiled August 25, 2026.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1934455194.USD","BK4532","BMED","BK4588","LU0109394709.USD","LU2112291526.USD","SG9999015986.USD","BBH","LU0058720904.USD","IE00BSNM7G36.USD","LU1934455863.HKD","IE00B19Z3B42.SGD","LU0965509010.AUD","LU0861579265.USD","LU2324357040.USD","BK4139","LU0823416689.USD","LU0859254822.USD","IE00BZ1G4Q59.USD","LU1023059063.AUD","LU0889565916.HKD","BIB","MEDI","IE00B3T34201.USD","LU1674673428.USD","BK4585","BK4578","LU0114720955.EUR","LU0289739699.SGD","LU1061106388.HKD","LU0320765992.SGD","LU1585245621.USD","LU2468319806.SGD","LU2089984988.USD","LU0965508806.USD","LU0965509101.SGD","LU0965509283.SGD","SG9999015952.SGD","LU1571399168.USD","LU0122379950.USD","LU1037948541.HKD","LU1057294990.SGD","LU1934455277.USD","BK4566","LU0882574055.USD","GILD","LU1037948897.HKD","BK4583","IBB","LU0234570918.USD","LU1066051498.USD","BK4568","LU1066053197.SGD","LU1839511570.USD","LU2357627491.SGD","SG9999015978.USD","TBXU","IE00BKVL7J92.USD","LU1778281490.HKD","LU2087621335.USD","SG9999015945.SGD","IBBQ","TMED","BK4550","LU1674673691.USD","LU1430594728.SGD","IE00B19Z3581.USD","IE0002270589.USD","IE00B7SZLL34.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662752593","title":"Moderna Inc. Stock Rallies 14.4%, Outperforms Peers","url":"https://stock-news.laohu8.com/highlight/detail?id=2662752593","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662752593?lang=en_us&edition=fundamental","pubTime":"2026-08-26 04:33","pubTimestamp":1787689980,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Moderna Inc. surged 14.4% to $158.83 on what proved to be an all-around favorable trading session for the stock market, with the NASDAQ Composite Index rising 0.7% to 26,151.30 and the Dow Jones Industrial Average rising 0.3% to 53,577.40.Moderna Inc. closed 10.1% short of its 52-week high of $176.66, which the company achieved on August 19th.The stock outperformed some of its peers, as Johnson & Johnson rose 0.5% to $273.14, Pfizer Inc. rose 2.1% to $28.57, and Gilead Sciences Inc. rose 1.38% to $148.77.Trading volume totaled 48.9 million, compared to the 50-day average of 15.2 million.Data source: Dow Jones Market Data, FactSet","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2468319806.SGD","LU1057294990.SGD","MRNY","LU0859254822.USD","LU1037948541.HKD","BK4583","IE00B7SZLL34.SGD","BK4534","IE0002270589.USD","LU0114720955.EUR","IE00B3T34201.USD","LU1674673428.USD","LGHT","LU1061106388.HKD","GNOM","LU0320765992.SGD","MEDI","MRNA","SG9999015952.SGD","BK4566","SG9999015978.USD","WDNA","BIB","BMED","LU2089984988.USD","MRNX","IDNA","BK4548","TMED","BK4568","BK4588","BBH","LU0889565916.HKD","LU0965509101.SGD","LU0965509283.SGD","LU1023059063.AUD","LU1430594728.SGD","SG9999015986.USD","GILD","TBXU","LU0058720904.USD","IE00BSNM7G36.USD","LU1037948897.HKD","BK4533","IBBQ","IE00B19Z3581.USD","LU0965509010.AUD","LU1839511570.USD","IBB","LU0823416689.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662370257","title":"Political and General News Events from August 25","url":"https://stock-news.laohu8.com/highlight/detail?id=2662370257","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662370257?lang=en_us&edition=fundamental","pubTime":"2026-08-25 21:25","pubTimestamp":1787664343,"startTime":"0","endTime":"0","summary":"DIARY-Political and General News Events from August 25Aug 25 (Reuters)-For other diaries, please see:Political andGeneral NewsPOL/DIARYTop Economic EventsM/DIARYEmerging Markets Economic EventsEMRG/DI","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260825:nL4N44M0UU:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BBH","IBBQ","LU1023059063.AUD","LU0320765992.SGD","BK4533","BK4566","IE0002141913.USD","TBXU","IE00BJJMRZ35.SGD","LU0889565916.HKD","LU2242652126.USD","LU2468319806.SGD","LU1571399168.USD","LU2242646821.SGD","BK4534","BIB","BK4599","LU1061106388.HKD","PBE","IE00B2B36J28.USD","IE00BFTCPJ56.SGD","IE0009355771.USD","BK4588","IE00B4R5TH58.HKD","BK4585","LU2089984988.USD","LU1057294990.SGD","LU0289739699.SGD","IE00BJT1NW94.SGD","LU0058720904.USD","LU2112291526.USD","LU0122379950.USD","LU1983299246.USD","SG9999001440.SGD","AMGN","IBB","BK4139","LU0868494617.USD","LU0109394709.USD","PJP","BK4581"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662786682","title":"Viavi Solutions (VIAV) Could Be 40% Undervalued On Vertex 6.0 Launch","url":"https://stock-news.laohu8.com/highlight/detail?id=2662786682","media":"Simply Wall St.","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662786682?lang=en_us&edition=fundamental","pubTime":"2026-08-25 12:37","pubTimestamp":1787632638,"startTime":"0","endTime":"0","summary":"Viavi Solutions (VIAV) has launched Vertex 6.0, a new version of its channel emulation platform designed for 6G and Wi-Fi 7/8 testing. Investors are assessing what this expanded wireless testing capability might imply for the stock.\nSee our latest analysis for Viavi Solutions.\nThe Vertex 6.0 launch arrives after a sharp pullback in Viavi Solutions' share price, with the stock down 20.13% over the past week and 31.31% over 90 days. However, year to date the share price return is 103.58% and...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/8111000-choice1-main-header/1585186745276","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/8111000-choice1-main-header/1585186745276"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/tech/nasdaq-viav/viavi-solutions/news/viavi-solutions-viav-could-be-40-undervalued-on-vertex-60-la","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/tech/nasdaq-viav/viavi-solutions/news/viavi-solutions-viav-could-be-40-undervalued-on-vertex-60-la","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LU2065169927.USD","IE00BFTCPJ56.SGD","LU0757428866.USD","IBB","BIB","LU0205194284.USD","IBBQ","LU2065170008.USD","LU0079474960.USD","LU2462157665.USD","IE00BJJMRZ35.SGD","LU2065171311.SGD","BK4139","VERX","LU1778281490.HKD","LU1093756168.USD","LU2417539215.USD","IE00B19Z3581.USD","LU1559883803.SGD","LU2362540622.SGD","LU1093756325.SGD","BBH","TBXU","VRTX","BK4020","BK4567","IE00B4R5TH58.HKD","IE0002141913.USD","SG9999013999.USD","IDNA","VIAG","LU2237438978.USD","GNMX","IE00B894F039.SGD","VIAV","LU0234570918.USD","LU2089984988.USD","IE00B19Z9P08.USD","LU1069344957.HKD","LU0289739699.SGD","LU0240877869.USD","IE0002270589.USD","LU2468319806.SGD","LU2362541273.HKD","PBE","BK4023","LU2236285917.USD","IE00BZ9MQY76.HKD","IE0009355771.USD","LU1585245621.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662820617","title":"Moderna Inc. Stock Slides 4.3%, Underperforms Peers","url":"https://stock-news.laohu8.com/highlight/detail?id=2662820617","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662820617?lang=en_us&edition=fundamental","pubTime":"2026-08-25 04:34","pubTimestamp":1787603640,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Moderna Inc. slipped 4.3% to $138.89 on what proved to be an all-around mixed trading session for the stock market, with the Dow Jones Industrial Average rising 0.3% to 53,417.16 and the NASDAQ Composite Index falling 0.8% to 25,980.19.Moderna Inc. closed 21.4% short of its 52-week high of $176.66, which the company reached on August 19th.The stock underperformed when compared to some of its peers, as Johnson & Johnson rose 1.0% to $273.04, Pfizer Inc. fell 0.4% to $27.97, and Gilead Sciences Inc. rose 0.42% to $146.74.Trading volume totaled 31.3 million, compared to the 50-day average of 14.7 million.Data source: Dow Jones Market Data, FactSet","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","GNOM","IDNA","LU0122379950.USD","LU1061106388.HKD","LU1585245621.USD","IE00BKVL7J92.USD","LU0114720955.EUR","LU1934455277.USD","IBB","IE00B19Z3B42.SGD","LU0109394709.USD","BK4548","LU2357627491.SGD","BK4534","BK4578","IE00B3T34201.USD","IE0002270589.USD","LU2324357040.USD","TMED","GILD","BIB","MRNX","BMED","LU0234570918.USD","LU0289739699.SGD","LU0320765992.SGD","LU0859254822.USD","LU1037948541.HKD","LU1037948897.HKD","SG9999015986.USD","LU2468319806.SGD","MRNY","IE00B19Z3581.USD","LU1057294990.SGD","IBBQ","BBH","LU1839511570.USD","LU2089984988.USD","SG9999015952.SGD","WDNA","LU0965509283.SGD","MRNA","LGHT","BK4532","IE00BSNM7G36.USD","TBXU","MEDI","BK4568","BK4566"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662206197","title":"Amgen Inc. Stock Underperforms Monday When Compared to Competitors Despite Daily Gains","url":"https://stock-news.laohu8.com/highlight/detail?id=2662206197","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662206197?lang=en_us&edition=fundamental","pubTime":"2026-08-25 04:34","pubTimestamp":1787603640,"startTime":"0","endTime":"0","summary":"DJ Amgen Inc. Stock Underperforms Monday When Compared To Competitors Despite Daily GainsThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Amgen Inc.  rallied 1.03% to $443.84 Monday, on what proved to be an all-around mixed trading session for the stock market, with the Dow Jones Industrial Average  rising 0.26% to 53,417.16 and the S&P 500 Index  falling 0.28% to 7,652.86.This was the stock's second consecutive day of gains.Amgen Inc. hit a new 52-week high, surpassing its previous peak of $443.20, which the company reached on August 19th.The stock demonstrated a mixed performance when compared to some of its competitors Monday, as Johnson & Johnson  rose 1.04% to $273.04, Pfizer Inc.  fell 0.36% to $27.97, and AbbVie Inc.  fell 0.17% to $264.52.Trading volume  remained 382,792 below its 50-day average volume of 2.8 M.Data source: Dow Jones Market Data, FactSet. Data compiled August 24, 2026.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BIB","IE0009355771.USD","LU1057294990.SGD","TBXU","BK4533","BK4588","SG9999001440.SGD","BK4585","LU1983299246.USD","LU1061106388.HKD","LU2112291526.USD","BBH","IE00B2B36J28.USD","BK4581","LU0320765992.SGD","LU2242646821.SGD","IE00BJT1NW94.SGD","LU1023059063.AUD","LU0109394709.USD","LU0122379950.USD","IE00BFTCPJ56.SGD","PJP","IE0002141913.USD","LU2242652126.USD","BK4599","04332","LU0289739699.SGD","LU0868494617.USD","PBE","IE00B4R5TH58.HKD","LU2468319806.SGD","LU0058720904.USD","BK4139","IBB","AMGN","LU1571399168.USD","LU2089984988.USD","IBBQ","BK4534","IE00BJJMRZ35.SGD","LU0889565916.HKD","BK4566"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662205709","title":"Lakefront Biotherapeutics Wins FDA Orphan Drug Status for Gamgertamig in Pemphigus","url":"https://stock-news.laohu8.com/highlight/detail?id=2662205709","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662205709?lang=en_us&edition=fundamental","pubTime":"2026-08-25 04:01","pubTimestamp":1787601693,"startTime":"0","endTime":"0","summary":"Lakefront Biotherapeutics wins FDA orphan drug status for gamgertamig in pemphigusFDA granted orphan drug designation to gamgertamig for pemphigus.The drug already holds FDA fast track and orphan stat","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260824:nNDL5cnKbj:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IBBQ","LU0234570918.USD","LU0861579265.USD","LU1430594728.SGD","BK4550","SG9999014013.SGD","IE00BQXX3F31.USD","IE00B64PRP62.GBP","SG9999015952.SGD","IE0002270589.USD","SG9999015978.USD","TBXU","IE00B19Z3B42.SGD","TMED","IE00BN0W2W23.USD","IE00BKVL7J92.USD","LU1066051498.USD","LU2324357040.USD","MEDI","IE00BN0W2V16.EUR","LU2089984988.USD","LU1037948541.HKD","BK4578","BK4568","LU0965508806.USD","BCDF","BBH","IE00BN0W2T93.GBP","NDAQ","GILD","LU0859254822.USD","LU1023059063.AUD","SG9999014039.USD","LU1674673691.USD","IE00BZ1G4Q59.USD","LU0320765992.SGD","IE00BKPKM429.USD","LU2210150020.SGD","LU0965509010.AUD","BMED","LU2087621335.USD","BK4139","LU0122379950.USD","IBB","IE00BQXX3C00.GBP","LU2210149790.SGD","BIB","BK4566","LU0289739699.SGD","LU2095319765.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662729270","title":"Amgen Extends MariTide Study In Obesity And Diabetes, Keeping Investor Focus On Long-Term Potential","url":"https://stock-news.laohu8.com/highlight/detail?id=2662729270","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662729270?lang=en_us&edition=fundamental","pubTime":"2026-08-25 00:31","pubTimestamp":1787589063,"startTime":"0","endTime":"0","summary":"Amgen Inc ($AMGN) announced an update on their ongoing clinical study. Amgen Inc. is moving ahead with MARITIME-2-EXTENSION, a Phase 3 trial that t...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/amgen-extends-maritide-study-in-obesity-and-diabetes-keeping-investor-focus-on-long-term-potential?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/amgen-extends-maritide-study-in-obesity-and-diabetes-keeping-investor-focus-on-long-term-potential?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1023059063.AUD","TBXU","LU0320765992.SGD","AMGN","LU0058720904.USD","BBC","BBH","LU2242652126.USD","BK4139","BIB","IE0002141913.USD","BK4566","BK4585","BK4581","IE00BJJMRZ35.SGD","BK4599","LU0868494617.USD","LU1057294990.SGD","LU1983299246.USD","IE00BFTCPJ56.SGD","PJP","LU2089984988.USD","IE0009355771.USD","LU1571399168.USD","LU2242646821.SGD","LU0109394709.USD","IE00B2B36J28.USD","LU0889565916.HKD","IBBQ","IE00BJT1NW94.SGD","BK4533","LU2112291526.USD","IBB","SG9999001440.SGD","LU0122379950.USD","LU0289739699.SGD","BK4534","LU1061106388.HKD","PSIL","LU2468319806.SGD","PBE","IE00B4R5TH58.HKD","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661271512","title":"Political and General News Events from August 24","url":"https://stock-news.laohu8.com/highlight/detail?id=2661271512","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661271512?lang=en_us&edition=fundamental","pubTime":"2026-08-24 21:19","pubTimestamp":1787577552,"startTime":"0","endTime":"0","summary":"DIARY-Political and General News Events from August 24Aug 24 (Reuters)-For other diaries, please see:Political andGeneral NewsPOL/DIARYTop Economic EventsM/DIARYEmerging Markets Economic EventsEMRG/DI","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260824:nL4N44L0XV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4534","LU0109394709.USD","IBBQ","BK4533","LU0889565916.HKD","IE0009355771.USD","BK4581","LU1983299246.USD","LU0122379950.USD","IE00BFTCPJ56.SGD","LU2242646821.SGD","BK4585","BK4588","IE0002141913.USD","BIB","BK4566","TBXU","LU2112291526.USD","IE00BJJMRZ35.SGD","BK4139","IE00BJT1NW94.SGD","LU1061106388.HKD","LU1057294990.SGD","SG9999001440.SGD","LU2089984988.USD","LU1023059063.AUD","AMGN","LU2468319806.SGD","BK4599","LU1571399168.USD","LU0320765992.SGD","BBH","IBB","IE00B2B36J28.USD","LU0868494617.USD","LU2242652126.USD","IE00B4R5TH58.HKD","PBE","PJP","LU0058720904.USD","LU0289739699.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661278374","title":"EU Commission Approves Gilead Trodelvy-Keytruda Combo for First-Line PD-L1+ Metastatic TNBC","url":"https://stock-news.laohu8.com/highlight/detail?id=2661278374","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661278374?lang=en_us&edition=fundamental","pubTime":"2026-08-24 18:31","pubTimestamp":1787567503,"startTime":"0","endTime":"0","summary":"EU Commission approves Gilead Trodelvy-Keytruda combo for first-line PD-L1+ metastatic TNBCEuropean Commission granted marketing authorization for Trodelvy with Merck’s Keytruda in first-line metastat","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260824:nNDL4gZS8y:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GILD","BK4566","LU0965509283.SGD","LU1430594728.SGD","LU0109394709.USD","BIB","LU1037948897.HKD","LU0320765992.SGD","LU2357627491.SGD","BMED","LU0114720955.EUR","LU1061106388.HKD","LU1934455194.USD","TMED","LU1934455863.HKD","BBH","LU0289739699.SGD","IBBQ","LU0823416689.USD","MEDI","LU1037948541.HKD","LU0965509010.AUD","LU1057294990.SGD","LU2089984988.USD","LU1778281490.HKD","LU0965508806.USD","BK4583","BK4585","SG9999015952.SGD","IE00B3T34201.USD","LU1674673691.USD","LU0965509101.SGD","TBXU","LU1066051498.USD","IE00B19Z3581.USD","IE00BZ1G4Q59.USD","LU0859254822.USD","LU0861579265.USD","LU1934455277.USD","LU0058720904.USD","SG9999015978.USD","IE0002270589.USD","LU1023059063.AUD","LU0882574055.USD","SG9999015986.USD","IBB","LU1585245621.USD","BK4550","LU2468319806.SGD","LU1571399168.USD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":3,"totalSize":200,"code":"91000000","status":"200"}]}}